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Circulating endothelial progenitor cells decrease in
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Background: Endothelial progenitor cells (EPC) contribute to vascular regeneration. Since surgical injury and burns
induce a pro-inflammatory and proangiogenic response, we investigated the effect of vascular injury withminimal surgical
trauma after endarterectomy on the number of circulating EPC and systemic inflammatory changes.
Methods and Results: Forty-five patients with peripheral arterial occlusive disease were included in the study. Venous blood
samples were taken before and 1 day after endarterectomy and plaque material was obtained. Ten patients with minor
surgery served as controls. Circulating CD133CD34, VEGFR-2CD34 progenitor cells and surface expression of
CD11b on circulating neutrophils were analysed using flow cytometry. EPCs were characterized in a culture assay as
double-positive for DiI-LDL uptake and lectin binding. Cytokine concentrations of interleukin (IL)-6, IL-8, TNF-,
IL-1ß, IL-10, IL-12, SDF-1, G-CSF, and VEGF were measured in plasma and tissue samples. After endarterectomy a
significant decrease in circulating EPC, CD133CD34, and VEGFR-2CD34 cells was observed. This was
associated with a specific pattern of changes in circulating cytokine levels after endarterectomywith a decrease in IL-1 beta
and IL-12, an increase in IL-6 and G-CSF plasma concentrations, and surface expression of CD11b on circulating
neutrophils. In contrast, after minor surgery an increase in circulating CD133CD34 cells, IL-6, IL-8, and IL-10 was
found. Interestingly there was a negative association between levels of local IL-6 within the plaque and only the
preoperative levels of circulating CD133C34.
Conclusion: Endarterectomy induces changes in circulating cytokines and a decline in circulating progenitor cells, which
may be due to recruitment of progenitor cells to the injured vessels. This is supported by the negative association between
plaque inflammation and circulating progenitor cells before endarterectomy. (J Vasc Surg 2008;48:1217-22.)Endothelial progenitor cells (EPCs) represent a poten-
tial repair mechanism of the organism for vascular lesions.
Tissue damage such as myocardial infarction,1 severe burns,
or bypass surgery2 increase the number of circulating en-
dothelial progenitor cells. Mobilized from the bone mar-
row, progenitor cells are recruited to ischemic areas
through specific chemokine and integrin interactions3 and
contribute to neovascularization and tissue regeneration.4
Increased progenitor cell release from the bone marrow is
part of the host defense during inflammation as a result of
injury-mediated release of stress signals. This release is
induced by a wide range of cytokines such as granulocyte
colony-stimulating factor (G-CSF), granulocyte-macrophage
colony-stimulating factor (GM-CSF), stem cell factor
(SCF), and chemokines such as interleukin (IL)-8,Mip-1,
Gro-ß, and stromal derived factor (SDF)-1.3
In this study, one aimwas to investigate the influence of
vascular injury induced by endarterectomy and its effect on
circulating hematopoietic CD34CD133 and endothe-
lial CD34VEGFR2 progenitor cells.
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doi:10.1016/j.jvs.2008.06.018Atherosclerosis was identified as a disease not only due
to lipid accumulation, but as a process of endothelial dys-
function and subendothelial inflammation resulting in re-
generative responses of the vessel wall. Local release of
mediators from endothelial cells and leukocytes within
atherosclerotic plaques is fundamental for plaque progres-
sion.5,6 Epidemiological studies showed an increased vas-
cular risk for patients with elevated acute-phase proteins
such as C-reactive protein and different cytokines like IL-6
and TNF-.7 Previous investigations including patients
undergoing endarterectomy mainly explored histological
composition of atherosclerotic plaque material and local
cytokine expressions.
In this study, in addition to the local inflammation of
atherosclerotic plaques, the systemic inflammatory reaction
and its cytokine pattern after endarterectomy were exam-
ined. Furthermore, we sought to investigate the association
between circulating endothelial and hematopoietic progen-
itor cells and systemic or local inflammation.
METHODS
Patient selection. The study group comprised of 45
patients with symptomatic peripheral arterial occlusive dis-
ease with stenosis ranging from 85-99% undergoing end-
arterectomy of carotid, iliac, or femoral artery. Stenosis of
85% ormore was confirmed either by catheter angiography,
duplex scanning, or magnetic resonance angiography of the
respective artery. To minimize confounding factors, pa-
tients with chronic inflammatory disease or acute ischemia
were excluded. Carotid endarterectomy was performed in
“no touch” technique, using a shunt to maintain sufficient
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tional open endarterectomy with longitudinal arteriotomy
and closure by a collagen coated Dacron patch. Endarter-
ectomy of femoral and iliac artery was performed using a
semi-closed technique and a Vollmar ringstripper accord-
ing to customary practice. Venous blood samples were
taken on admission and 15-18 hours after endarterectomy.
Excised atherosclerotic plaque material was attained during
surgery. To estimate the impact of surgery without exten-
sive vascular injury, a control group comprising of 10
patients with elective implantation of a pacemaker or an
internal defibrillator device was analyzed. The study proto-
col was approved by the institutional ethics committee and
informed consent was obtained from all subjects.
Immunoassays. Serum from venous blood samples
were frozen and stored at 80°C. Concentrations of IL-1ß,
TNF-, IL-6, IL-8, IL-10, IL-12, and G-CSF were deter-
minedby immunoassays (CBAHuman InflammationKit, BD
Biosciences, San Diego, Calif; G-CSF Immunoassay Quan-
tikine R&D Systems, Minneapolis, Minn). Detection limits
were 2.5 pg/mL for IL-6, 3.6 pg/mL for IL-8, 3.3 pg/mL
for IL-10, 1.9 pg/mL for IL-12, 7.2 pg/mL for IL-1ß, 3.7
pg/mL for TNF-, and 20 pg/mL for G-CSF. Intra-assay
variability for the lower assay range were10%.
Atherosclerotic plaque material. The atherosclerotic
plaque material was attained during surgery, then frozen
and stored at -80°C. Afterwards, atherosclerotic tissue was
lysed and total protein content was determined using BCA
Protein Assay Kit (Pierce, Rockford, Ill). Local levels of
IL-12, TNF-, IL-10, IL-6, IL-1 ß, and IL-8 were mea-
sured and results stated as proportion of total protein.
Flow cytometry. To analyze circulating progenitor
cells 2.5 mL of heparinized full blood samples were stained
according to a modified protocol of the EuropeanWorking
Group on Clinical Cell Analysis.1 Vital CD133CD34
CD45-7AAD- progenitor cells were determined by stain-
ing with fluorescein isothiocyanate (FITC)-conjugated
anti-CD34, PE-conjugated anti-CD133, APC-conjugated
anti-CD45, and 7AAD (BD Biosciences), additional mea-
surements were performed to determine the absolute num-
bers using True Count beads (Becton Dickinson, Mountain
View, Calif). CD34CD31 vascular endothelial growth
factor (VEGF)-receptor-2 endothelial progenitor cells were
determined by staining with PE-conjugated anti-VEGFR2,
FITC-conjugated anti-CD31 (Beckman Coulter, Fullerton,
Calif) and APC-conjugated anti-CD34 (BD Biosciences). To
analyze activated granulocytes surface expression of CD11b
on CD45CD15 cells was determined using FITC-conju-
gated anti-CD11b, APC-conjugated anti-CD45, and PerCP-
conjugated anti-CD15 (BD Biosciences). Fluorescence iso-
type-matched antibodies were used as controls. Flow
cytometric analysis was performed using a FACS Calibur
(Becton Dickinson). Fluorescence intensity of at least
200,000 cells was recorded and analyzed using CellQuest
software (BD Biosciences, San Jose, Calif).
Culture assay of EPCs. Mononuclear cells were iso-
lated from 5 mL EDTA-anticoagulated blood samples us-
ing Ficoll (Pharmacia Biotech, Freiburg, Germany) gradientseparation. Mononuclear cells (5  10’6 cells per 24-well
plate) were cultured on fibronectin coated cover slides in
EGM-2 medium (Cambrex Clonetics, Baltimore, Md). After
4 days of culture, adherent EPCswere identified by expression
of 1,10-dioctadecyl-3,3,30,30-tetramethylindocarbocyanin-
eperchlorate-labelled acetylated LDL (DiI-acLDL) incorpo-
ration and Ulex europaeus agglutinin-I (Sigma-Aldrich,
Munich, Germany) binding by direct fluorescent staining.
Four randomly selected fields from two cover slides were
counted for DiI-ac-LDL and FITC-lectin-positive cells as a
measure for EPCs.
Statistical analysis. Differences between more than 2
matched samples were tested by Friedman’s test followed
by Wilcoxon’s matched-pairs signed-ranks test, and differ-
ences between the study group and the control group by
the Mann-Whitney-Wilcoxon rank-sum test. A P value 
.05 in the two-tailed test was regarded as significant.
RESULTS
Patients and procedural characteristics. In the
present study, 45 patients with peripheral occlusive disease were
included. Thirty-four patients underwent elective endarterec-
tomy of the carotid artery, 11 patients of the femoral or iliac
artery. Patients were either symptomatic with Fontaine
classification stage II b or with transient ischemic attack.
There was no statistical difference concerning age, risk
factors, andmedical treatment between carotid and femoral
populations (Table I). All procedures were performed suc-
cessfully. Patients with chronic inflammatory diseases or
acute cardiovascular and cerebrovascular events, such as
myocardial infarction, percutaneous coronary intervention,
embolism and stroke, as well as surgery within the last 3
months were excluded. In the control group, all minor
surgery procedures were performed successfully. No com-
plication such as major bleeding, death, or cerebral events
occurred.
Circulating CD34CD133, VEGFR2CD34
and endothelial progenitor cells. Hematopoietic and en-
dothelial progenitor cells were measured before and after
endarterectomy. Levels of circulating CD34CD133
cells were significantly lower after endarterectomy compared
to preprocedural levels (Fig 1, A). Likewise postprocedural
levels of VEGFR2CD34 cells and endothelial progen-
itor cells defined as DiI-ac-LDL and FITC-lectin double
positive were decreased (Fig 1, B and C). This decrease in
circulating progenitor cells was similar in femoral and ca-
rotid endarterectomy patients. In contrast, after minor
surgery a 2.3  0.9 fold increase in circulating CD34
CD133 cells was observed (P  .05).
Systemic inflammation after endarterectomy.
Analysis of markers of systemic inflammation before and
after endarterectomy showed a significant postprocedural
increase in IL-6 and CRP, as well as an elevated surface
expression of CD11b on circulating neutrophils (Fig 2, A,
B, and C). Systemic levels of IL-12 and IL-1ß by contrast
showed a significant decrease (Fig 2, E and F). Analyzing
cytokines important for mobilization and homing of pro-
genitor cells, we found that levels of G-CSF showed a signif-
zyme
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no differences between preoperative and postoperative cy-
tokine levels between femoral and carotid populations.
After minor surgery, we found a significant increase in IL-6
(2.01  0.65 pg/mL; 12.93  6.21 pg/mL; P  .01),
IL-8 (7.61 1.74 pg/mL; 9.02 1.52 pg/mL; P .02)
and IL-10 (1.38 0.08 pg/mL; 1.61 0.07 pg/mL; P
.04). Pre- and postoperative IL-10 levels were higher in the
control group compared to study population (0.67 1.55
pg/mL; P  .01; 0.25  1.09 pg/mL; P  .01). No
differences or changes were seen in other measured cyto-
kines.
Atherosclerotic plaque inflammation. From the at-
tained atherosclerotic plaque material local levels of IL-12,
TNF-, IL-10, IL-6, IL-1ß, IL-8, and SDF-l were mea-
sured. Highest local concentrations were found for IL-8,
IL6, and IL-1ß, and lowest levels were measured for IL12,
IL10, and TNF- (Table II). Since IL-6 production of
vascular smooth muscle cells is known to contribute to
atherosclerosis in ApoE deficient mice, we sought to cate-
gorize the inflammatory potential within the plaque ac-
cording to IL-6 expression. Moreover, as infiltrating leu-
Fig 1. Circulating hematopoietic CD34CD133 (A). VEGFR-
2CD34 (B) and endothelial progenitor cells (C) decrease after
endarterectomy.
Table I. Baseline characteristics
Study patients (n  45) Carotis e
Age, y 69  1.5
Sex, M/F (%) 34/11 (76/24)
CAD, n (%) 13 (28)
Hypertension, n (%) 29 (64)
Diabetes, n (%) 13 (29)
Hypercholesteremia, n (%) 22 (49)
Nicotine, n (%) 9 (20)
Beta-Blocker, n (%) 19 (42)
ACE-Inhibitors, n (%) 19 (42)
Nitrates, n (%) 8 (18)
Statins, n (%) 26 (58)
Calcium Antagonists, n (%) 3 (7)
ASA/Clopidogrel, n (%) 40 (88)
CAD, Coronary artery disease; n, number; ACE, angiotensin-converting enkocytes may further aggravate local inflammation, we alsoassessed IL-8 levels. Because of the low number of patients,
we showed the data categorized as IL-6 positive and neg-
ative plaques.
Forty-eight percent of all plaques were expressing IL-6.
These were highly associated with local IL-8 levels (Fig 3, A),
suggesting that IL-6andIL-8may reflect localpro-inflammatory
changes within the plaque.
Association of local plaque inflammation and circu-
lating progenitor cells. Analyzing the association of
CD34CD133 circulating progenitor cells before surgery
and specific patterns of inflammatory cytokines within local
plaque tissue, we found that expression of IL-6 in plaque
material was negatively associated with circulating levels of
CD34CD133 progenitor cells (Fig 3, B) but not with
circulating EPC or VEGFR2CD34 cells (data not
shown). This association was only found for CD34
CD133 cells preoperatively and was abolished after plaque
removal. No association of circulating CD34CD133 cells
with systemic cytokines was found.
DISCUSSION
Major findings of our study are as follows: (1) Vascular
injury induced by endarterectomy results in a decline of
both circulating hematopoietic and endothelial progenitor
cells and (2) results in a systemic inflammatory response
with a specific pattern of inflammatory cytokines. (3) Ath-
erosclerotic plaques with detectable IL-6 were associated
with lower numbers of circulating CD133CD34 pro-
genitor cells. These results suggest that the local cytokine
expression of atherosclerotic plaques may relate to the
number of circulating progenitor cells. Considering circu-
lating progenitor cells as potential repair mechanism, our
results suggest that local IL-6-associated inflammation in
atherosclerotic plaques may, by so-far undefined mecha-
nisms, contribute to the recruitment of circulating
CD133CD34 progenitor cells.
Circulating progenitor cells after endarterectomy.
Tissue damage such as myocardial infarction,1 severe burns,
or bypass surgery2 have been shown to increase the number
erectomy (n  34) Femoral endarterectomy (n  11)
 1.6 69  3.7 P  .95
(74/26) 9/2 (81/9) P  .44
(29) 3 (27) P  .50
(62) 8 (73) P  .43
(26) 4 (36) P  .43
(47) 6 (55) P  .46
(21) 2 (18) P  .49
(50) 2 (18) P  .14
(50) 2 (18) P  .14
(12) 4 (36) P  .17
(59) 6 (54) P  .49
(9) 0 (0) P  .31
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tor for atherosclerotic disease progression,9 so that cyto-
kines that are involved in mobilizing and homeostasis of
progenitor cells are of high clinical relevance. Increased
progenitor cell release from the bone marrow is part of the
host defence during inflammation and a result of injury-
mediated release of stress signals. This release is induced
by a wide range of mediators: cytokines such as G-CSF,
GM-CSF, VEGF, SCF and chemokines such as IL-8, Mip-
1, Gro-ß, and SDF-1.3 Recently, circulating IL-8 was
identified as an independent predictor of progenitor cell
mobilization in patients with acute myocardial infarction.1
Our study showed that after endarterectomy levels of
circulating CD34CD133 cells, VEGFR2CD34
Fig 2. Systemic levels of interleukin (IL)-6 (A), C-reac
polymorphonuclear leukocytes (C), IL-12 (D), IL-1ß
(F) before and after endarterectomy.
Table II. Cytokine levels in plaque material
IL-12 (pg/mg) 4.1  0.5
TNF- (pg/mg) 2.9  0.36
IL-10 (pg/mg) 1.9  0.39
IL-6 (pg/mg) 6.7  1.91
IL-1ß (pg/mg) 11.3  1.97
IL-8 (pg/mg) 47.3  19.67
SDF-l (pg/mg) 907.9  116.42
Shown are mean values and standard errors.
IL, Interleuken; TNF, tumor necrosis factor; SDF, stromal derived factor.cells and endothelial progenitor cells were significantlylower compared to preprocedural levels. This decline of
circulating progenitor cells seems at first sight to be contra-
dictory to the above-mentioned study which showed rising
progenitor cells after severe burns or bypass surgery.2 One
rotein (B), surface expression of CD11b on circulating
and granulocyte colony-stimulating factor (G-CSF)
Fig 3. Relationship of interleukin (IL)-6 and IL-8 expression
in atherosclerotic plaques (A) and negative association of local
IL-6 expression and circulating CD34CD133 cells before
endarterectomy (B).tive p
(E)interpretation of the decrementing circulating progenitor
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tion. Experimental studies have identified posttraumatic
bone marrow suppression. Looking at cytokines important
for mobilization released by the postprocedural systemic
inflammatory reaction, we found a significant rise in G-CSF
levels, a cytokine well known to potently induce progenitor
cell mobilization from bonemarrow to peripheral blood. In
our control group, in which patients underwent surgery
without extensive vessel injury, we did not find a decrease in
circulating progenitor cells; instead we found a trend for
higher levels of circulating progenitor cells. In this context,
we assume that circulating progenitor cells may decline
after endarterectomy in spite of an increased mobilization,
because of consumption due to recruitment to the site of
vascular injury.
Systemic inflammatory changes after endarterectomy.
The current understanding of atherosclerosis is character-
ized as a process of endothelial dysfunction, subendothelial
inflammation and regenerative response. Increased vascular
risk was demonstrated in epidemiological studies for pa-
tients with elevated levels of cytokines such as interleukin-6
and TNF-, cell adhesion molecules such as intercellular
adhesion molecule-1 and P-selectin, and acute-phase pro-
teins such as C-reactive protein, fibrinogen and serum
amyloid A.7,8 So far, earlier investigations focused on his-
topathologic examinations of retrieved atherosclerotic
plaque after endarterectomy10 and some studies investi-
gated plaque cytokine levels,11,12 whereas little is known
about systemic inflammatory changes after endarterec-
tomy. We found that vascular injury by endarterectomy
induced systemic inflammation with an increase in circulat-
ing CRP, IL-6, and neutrophil surface expression of
CD11b, whereas other cytokines such as IL1ß and IL-12
decreased. Whereas, TNF-IL-8 and IL-10 known to con-
tribute to proinflamatory responses in sepsis13 and acute
coronary syndromes1,14 remained unchanged. Cytokine
changes after endarterectomy were different compared to
changes after surgery without extensive vascular injury of
the control group. Specific tissue damage of vascular injury
may, thus, stimulate unique patterns of cytokine release
that provoke distinct repair mechanisms.
Atherosclerotic plaque inflammation. Earlier stud-
ies with histopathologic examinations of atherosclerotic
plaque after endarterectomy showed that unstable plaques
were associated with extensive macrophage infiltration as a
sign of local inflammation.15 Elevated TNF-, IL-8, and
IL-6 levels have been found in atherosclerotic plaques
compared to normal vessels.16,17 Our study confirmed
expression of IL-6, IL-8, and IL-1ß in human atheroscle-
rotic plaques. The shown frequent and significant coexist-
ence of IL-6 and IL-8 further underlines the importance of
these cytokines in atherosclerotic plaque inflammation.
Association of local plaque inflammation and circu-
lating progenitor cells. Whereas previous studies identi-
fied the number of progenitor cells as a predictor for
atherosclerotic disease progression8 or investigated the role
of cytokines in atherosclerotic plaques,7 this study shows,
we believe for the first time, an association between localplaque inflammation and circulating progenitor cells. We
found that high detectable levels of local IL-6 inflammation
in atherosclerotic plaques were correlated with low pre-
procedural levels of circulating CD34CD133 progeni-
tor cells that was abolished postoperatively. No such an
association was seen for systemic levels of IL-6 or other
cytokines. Recent studies suggest that atherosclerosis-
prone areas have a very high endothelial turnover rate,
which is regenerated, at least in part, by bone marrow–
derived stem cells.9,11 So far the underlying mechanisms of
progenitor cell recruitment to the plaque is not completely
understood but local cytokines like SDF-1 as well as local
cell activation may contribute to this process.3 Yet the
number of circulating progenitor cells is not only altered by
recruitment to the vessel wall but also by release from the
bone marrow compartment. This process is driven by cir-
culating cytokines eg, G-CSF in addition to local changes
within the bone marrow.3 Thus the association of vessel
wall mediators with circulating number of progenitor cells
may somehow relate to an altered recruitment of progeni-
tor cells to the vessel wall whereas an association with
circulating cytokines may relate to mobilization from the
bone marrow.
Considering circulating progenitor cells as potential
repair mechanism, local inflammation may contribute to
vascular repair after endarterectomy. Therefore, a systemic
decrease in circulating progenitor cells may result.
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RECOUP THE LOUPES 
Despite extremely limited resources, surgeons in developing countries work to provide their 
patients with the best possible care. For many of these surgeons, technology such as loupes, 
which facilitate delicate procedures, is simply out of reach.  
One year ago, Loupes Around The World distributed its first pair of loupes to a plastic surgeon
in Phnom Penh, Cambodia. Before Loupes Around The World, this surgeon commonly 
repaired cleft lips and palates, and treated trauma patients with maxillofacial injuries without 
the benefit of surgical magnification. Since then, this not-for-profit organization has provided 
loupes to surgeons from Panama to India and continues to receive requests from surgeons 
around the world.  
Loupes Around The World is now recycling donated loupes via a program called “Recoup the 
Loupes.” Surgeons with unused loupes are asked to send them to the foundation; there, repairs 
can be made to adjustable loupes, and the telescopes from fixed loupes can be installed into 
new lenses and frames. For fixed loupes, optical measurements are taken to ensure that the 
loupes will meet the needs of each individual surgeon. 
Please send your unused loupes to:  
David C. Knight, M.D., F.A.C.S. 
Loupes Around The World 
c/o Surgical Associates of Waterbury 
1211 West Main St. 
Waterbury, CT 06708 
Loupes Around The World accepts loupes made by any manufacturer. For more information 
about Loupes Around The World, as well as information about how to contribute, please visit: 
www.loupesaroundtheworld.org. Upon receiving loupes, a letter of acknowledgment will be 
sent to the donor for tax purposes. Loupes Around the World is a 501(c)3 tax-exempt 
organization.  
